Achieving Optimal Outcomes in Chronic Lymphocytic Leukaemia

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.5, 2001-01, pp. : 593-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia: Considerations in the Elderly

By Goede Valentin Hallek Michael

Drugs & Aging, Vol. 28, Iss. 3, 2011-03 ,pp. : 163-176

Adis International

Access to resources Recommend Favorite

Management of Chronic Lymphocytic Leukaemia

By Kalil N. Cheson B.D.

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 9-27

Adis International

Access to resources Recommend Favorite

Fludarabine in chronic lymphocytic leukaemia

By Elter Thomas Hallek Michael Engert Andreas

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1641-1651

Informa Healthcare

Access to resources Recommend Favorite

Chronic lymphocytic leukaemia

By Singer Charles Goldstone Tony

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 350-353

Royal College Of Physicians

Access to resources Recommend Favorite

An update on the management of chronic lymphocytic leukaemia

By Yee Karen WL O’Brien Susan M Giles Francis J

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1535-1554

Informa Healthcare

Access to resources Recommend Favorite